Jiangsu Yuyue Medical Equipment & Supply (002223) Q3 2026 earnings summary

Executive summary

• Q3 revenue was RMB2.042bn, up 8.28% YoY; net income attributable to shareholders was RMB288.5m, up 9.55%.

• 9M revenue rose 1.02% to RMB6.611bn, while attributable net income fell 22.83% to RMB1.131bn; excluding non-recurring items, net income fell 11.28% to RMB1.037bn.

Financial highlights

• Q3 adjusted net income, excluding non-recurring items, was RMB276.2m, up 8.06% YoY; 9M adjusted net income was RMB1.037bn.

• 9M operating cash flow was RMB1.158bn, down 22.95% YoY; cash and cash equivalents at period-end were RMB970.4m.

• Period-end cash and bank balances rose 79.16% from year-end; accounts receivable increased 87.86%, reflecting higher ordinary-course credit sales.

Key financial ratios and metrics

• Q3 basic and diluted EPS were RMB0.2913, up 10.42% YoY; 9M basic and diluted EPS were RMB1.1356, down 22.68%.

• 9M weighted-average return on equity was 8.52%, down 2.73 percentage points YoY.

• Total assets were RMB16.172bn, up 0.54% from year-end; equity attributable to shareholders was RMB12.891bn, down 2.64%.